Ranibizumab in the treatment of choroidal neovascularization on the border of an inferior staphyloma associated with tilted disc syndrome.
OBJECTIVE
To describe a case of choroidal neovascularization (CNV) on the border of an inferior staphyloma associated with tilted disc syndrome treated with intravitreal ranibizumab.


METHODS
Observational case report.


METHODS
A patient with CNV on the border of an inferior staphyloma associated with tilted disc syndrome was imaged using fluorescein angiography, autofluorescence and spectral domain optical coherence tomography, and treated with intravitreal injections of ranibizumab.


RESULTS
The patient received 3 ranibizumab injections during the 9-month follow-up. The visual acuity improved from 20/40 to 20/32 and the foveal thickness reduced from 470 microns to 248 microns. The angiograms showed resolution of leakage associated with CNV. There were no adverse events.


CONCLUSIONS
Intravitreal ranibizumab is an efficacious and safe treatment in the management of choroidal neovascularization on the border of an inferior staphyloma associated with tilted disc syndrome.
Arias
Luis
L
Department of Ophthalmology,Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona. luisarias@telefonica.net
Monés
Jordi
J
N Engl J Med. 2006 Oct 5;355(14):1419-31
17021318
Br J Ophthalmol. 2010 Jan;94(1):2-13
19443462
Int Ophthalmol. 1988;12(2):131-5
2466011
Curr Eye Res. 2006 Sep;31(9):765-74
16966149
N Engl J Med. 2006 Oct 5;355(14):1432-44
17021319
Am J Ophthalmol. 1976 Jul;82(1):16-23
937453
Surv Ophthalmol. 1982 Jul-Aug;27(1):3-41
6753203
Trans Am Ophthalmol Soc. 1977;75:67-86
613534
Am J Ophthalmol. 1988 Jan 15;105(1):98-9
2447781
Br J Ophthalmol. 1984 Dec;68(12):869-72
6210100
Retina. 2008 Nov-Dec;28(10):1493-501
18667957